Literature DB >> 34734155

Evolution-inspired redesign of the LPS receptor caspase-4 into an interleukin-1β converting enzyme.

Pascal Devant1, Anh Cao1, Jonathan C Kagan1.   

Abstract

Innate immune signaling pathways comprise multiple proteins that promote inflammation. This multistep means of information transfer suggests that complexity is a prerequisite for pathway design. Herein, we test this hypothesis by studying caspases that regulate inflammasome-dependent inflammation. Several caspases differ in their ability to recognize bacterial LPS and cleave interleukin-1β (IL-1β). No caspase is known to contain both activities, yet distinct caspases with complementary activities bookend an LPS-induced pathway to IL-1β cleavage. Using caspase-1/4 hybrid proteins present in canines as a guide, we identified molecular determinants of IL-1β cleavage specificity within caspase-1. This knowledge enabled the redesign of human caspase-4 to operate as a one-protein signaling pathway, which intrinsically links LPS detection to IL-1β cleavage and release, independent of inflammasomes. We identified caspase-4 homologues in multiple carnivorans which display the activities of redesigned human caspase-4. These findings illustrate natural signaling pathway diversity and highlight how multistep innate immune pathways can be condensed into a single protein.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34734155      PMCID: PMC8559778          DOI: 10.1126/sciimmunol.abh3567

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  44 in total

1.  Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux.

Authors:  Sebastian Rühl; Petr Broz
Journal:  Eur J Immunol       Date:  2015-08-06       Impact factor: 5.532

2.  An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells.

Authors:  Ivan Zanoni; Yunhao Tan; Marco Di Gioia; Achille Broggi; Jianbin Ruan; Jianjin Shi; Carlos A Donado; Feng Shao; Hao Wu; James R Springstead; Jonathan C Kagan
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

3.  Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire.

Authors:  Leopold Eckhart; Claudia Ballaun; Marcela Hermann; John L VandeBerg; Wolfgang Sipos; Aumaid Uthman; Heinz Fischer; Erwin Tschachler
Journal:  Mol Biol Evol       Date:  2008-02-14       Impact factor: 16.240

4.  Human Monocytes Engage an Alternative Inflammasome Pathway.

Authors:  Moritz M Gaidt; Thomas S Ebert; Dhruv Chauhan; Tobias Schmidt; Jonathan L Schmid-Burgk; Francesca Rapino; Avril A B Robertson; Matthew A Cooper; Thomas Graf; Veit Hornung
Journal:  Immunity       Date:  2016-03-29       Impact factor: 31.745

5.  Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1.

Authors:  Monica L Gonzalez Ramirez; Marcin Poreba; Scott J Snipas; Katarzyna Groborz; Marcin Drag; Guy S Salvesen
Journal:  J Biol Chem       Date:  2018-02-06       Impact factor: 5.157

6.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.

Authors:  Xing Liu; Zhibin Zhang; Jianbin Ruan; Youdong Pan; Venkat Giri Magupalli; Hao Wu; Judy Lieberman
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

7.  Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome.

Authors:  Meghan A Wynosky-Dolfi; Annelise G Snyder; Naomi H Philip; Patrick J Doonan; Maya C Poffenberger; Daina Avizonis; Erin E Zwack; Amber M Riblett; Baofeng Hu; Till Strowig; Richard A Flavell; Russell G Jones; Bruce D Freedman; Igor E Brodsky
Journal:  J Exp Med       Date:  2014-03-17       Impact factor: 14.307

8.  Deciphering key features in protein structures with the new ENDscript server.

Authors:  Xavier Robert; Patrice Gouet
Journal:  Nucleic Acids Res       Date:  2014-04-21       Impact factor: 16.971

9.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

10.  Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro.

Authors:  Anna Gritsenko; Shi Yu; Fatima Martin-Sanchez; Ines Diaz-Del-Olmo; Eva-Maria Nichols; Daniel M Davis; David Brough; Gloria Lopez-Castejon
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

View more
  5 in total

Review 1.  Mechanisms of Gasdermin Recognition by Proteases.

Authors:  Zhonghua Liu; Brianna M Busscher; Marta Storl-Desmond; Tsan Sam Xiao
Journal:  J Mol Biol       Date:  2021-09-29       Impact factor: 5.469

2.  Resurrection of an ancient inflammatory locus reveals switch to caspase-1 specificity on a caspase-4 scaffold.

Authors:  Betsaida Bibo-Verdugo; Isha Joglekar; Mithun N Karadi Giridhar; Monica L Ramirez; Scott J Snipas; A Clay Clark; Marcin Poreba; Guy S Salvesen
Journal:  J Biol Chem       Date:  2022-04-12       Impact factor: 5.486

Review 3.  Diverse Control Mechanisms of the Interleukin-1 Cytokine Family.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  Front Cell Dev Biol       Date:  2022-06-27

Review 4.  Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature.

Authors:  Anna E Gauthier; Randi D Rotjan; Jonathan C Kagan
Journal:  Open Biol       Date:  2022-10-05       Impact factor: 7.124

5.  Cleavage-Mediated Regulation of Myd88 Signaling by Inflammasome-Activated Caspase-1.

Authors:  Monika Avbelj; Iva Hafner-Bratkovič; Duško Lainšček; Mateja Manček-Keber; Tina Tinkara Peternelj; Gabriela Panter; Steven P Treon; Boris Gole; Uroš Potočnik; Roman Jerala
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.